Selskabets formål er handels- og produktionsvirksomhed.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 240.1 mio. | 4.9 mio. | 136 mio. | 1.5 mio. | 118 | |
CVR: 10504570
Secondary names: BOMMICE A/S, BOMTEST A/S, BOMHOLTGÅRD BREEDING AND RESEARCH CENTRE LTD.A/S
1 properties
Upgrade to Pro to see addresses, building data and ownership details
Companies in the same industry and area
CVR 31335094
CVR 45543943
CVR 18381737
CVR 45910733
CVR 34936250
Compared to 225 companies in Avl af andre dyr
Comparison is based on industry median values
The financial health of TACONIC BIOSCIENCES A/S shows a positive turnaround, with revenue increasing from 219.6 million DKK in 2023 to 240.1 million DKK in 2024, alongside a significant rise in profit from 466,587 DKK to 4.9 million DKK. Despite previous years of losses and negative equity, the company has improved its equity position to 1.5 million DKK in 2024, indicating a recovery in financial stability. However, concerns remain regarding its historical debt levels and the sustainability of profit margins moving forward. Positioned within the animal breeding industry, TACONIC BIOSCIENCES is gaining traction, but continued focus on maintaining profitability and managing equity will be crucial for future growth.
AI-generated summary
companydata.dk